By Professor Herbert Herzog

Journal articles

Menard C; Cavanagh C; Tse YC; Chabot J; Herzog H; Schwarzer C; Ferland G; Quirion R; Wong TP; Gaudreau P, 2014, 'O4‐09‐03: LOW HIPPOCAMPAL PRODYNORPHIN LEVELS ARE ASSOCIATED WITH MAINTENANCE OF MEMORY IN VARIOUS AGING RODENT MODELS', Alzheimer's & Dementia, 10, http://dx.doi.org/10.1016/j.jalz.2014.04.435

Huang L; Tan H; Fogarty M; Stark R; Andrews Z; Veldhuis J; Herzog H; Chen C; Steyn F, 2014, 'OR3-5: NPY neurons as a critical hypothalamic node for the control of GH release relative to food intake', Growth Hormone & IGF Research, 24, pp. S11 - S11, http://dx.doi.org/10.1016/s1096-6374(14)50027-5

Ménard C; Herzog H; Schwarzer C; Quirion R, 2014, 'Possible Role of Dynorphins in Alzheimer's Disease and Age-Related Cognitive Deficits', Neurodegenerative Diseases, 13, pp. 82 - 85, http://dx.doi.org/10.1159/000353848

Sala MSL; Hurtado MD; Brown AR; Bohórquez DV; Liddle RA; Herzog H; Zolotukhin S; Dotson CD, 2013, 'Modulation of taste responsiveness by the satiation hormone peptide YY', FASEB Journal, 27, pp. 5022 - 5033, http://dx.doi.org/10.1096/fj.13-228064

Shi YC; Lin Z; Lau J; Zhang H; Yagi M; Kanzler I; Sainsbury A; Herzog H; Lin S, 2013, 'PYY3-36 and pancreatic polypeptide reduce food intake in an additive manner via distinct hypothalamic dependent pathways in mice', Obesity, 21, http://dx.doi.org/10.1002/oby.20534

Hurtado MD; Sergeyev VG; Acosta A; Spegele M; La Sala M; Waler NJ; Chiriboga-Hurtado J; Currlin SW; Herzog H; Dotson CD; Gorbatyuk OS; Zolotukhin S, 2013, 'Salivary peptide tyrosine-tyrosine 3-36 modulates ingestive behavior without inducing taste aversion', Journal of Neuroscience, 33, pp. 18368 - 18380, http://dx.doi.org/10.1523/JNEUROSCI.1064-13.2013

Painsipp E; Köfer MJ; Farzi A; Dischinger US; Sinner F; Herzog H; Holzer P, 2013, 'Neuropeptide y and peptide YY protect from weight loss caused by Bacille Calmette-Guérin in mice', British Journal of Pharmacology, 170, pp. 1014 - 1026, http://dx.doi.org/10.1111/bph.12354

Sousa DM; McDonald MM; Mikulec K; Peacock L; Herzog H; Lamghari M; Little DG; Baldock PA, 2013, 'Neuropeptide y modulates fracture healing through Y1 receptor signaling', Journal of Orthopaedic Research, 31, pp. 1570 - 1578, http://dx.doi.org/10.1002/jor.22400

Purtell L; Herzog H, 2013, 'PYY', , pp. 1307 - 1313, http://dx.doi.org/10.1016/B978-0-12-385095-9.00178-0

Shi YC; Lau J; Lin Z; Zhang H; Zhai L; Sperk G; Heilbronn R; Mietzsch M; Weger S; Huang XF; Enriquez R; Castillo L; Baldock P; Zhang L; Sainsbury A; Herzog H; Lin S, 2013, 'Erratum: Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN (Cell Metabolism 17 (236-248))', Cell Metabolism, 18, pp. 144, http://dx.doi.org/10.1016/j.cmet.2013.06.012

Romero-Picó A; Vázquez MJ; González-Touceda D; Folgueira C; Skibicka KP; Alvarez-Crespo M; Van Gestel MA; Velásquez DA; Schwarzer C; Herzog H; López M; Adan RA; Dickson SL; Diéguez C; Nogueiras R, 2013, 'Hypothalamic κ-opioid receptor modulates the orexigenic effect of ghrelin', Neuropsychopharmacology, 38, pp. 1296 - 1307, http://dx.doi.org/10.1038/npp.2013.28

Bervini S; Herzog H, 2013, 'Mouse models of Prader-Willi Syndrome: A systematic review', Frontiers in Neuroendocrinology, 34, pp. 107 - 119, http://dx.doi.org/10.1016/j.yfrne.2013.01.002

Liu M; Mountford SJ; Zhang L; Lee IC; Herzog H; Thompson PE, 2013, 'Synthesis of BVD15 peptide analogues as models for radioligands in tumour imaging', International Journal of Peptide Research and Therapeutics, 19, pp. 33 - 41, http://dx.doi.org/10.1007/s10989-012-9330-z

Shi YC; Lau J; Lin Z; Zhang H; Zhai L; Sperk G; Heilbronn R; Mietzsch M; Weger S; Huang XF; Enriquez RF; Baldock PA; Zhang L; Sainsbury A; Herzog H; Lin S, 2013, 'Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN', Cell Metabolism, 17, pp. 236 - 248, http://dx.doi.org/10.1016/j.cmet.2013.01.006

Howell OW; Silva S; Scharfman HE; Sosunov AA; Zaben M; Shtaya A; McKhann G; Herzog H; Laskowski A; Gray WP, 2013, 'Corrigendum to "Neuropeptide Y is important for basal and seizure-induced precursor cell proliferation in the hippocampus" [Neurobiol. Dis. 26/1 (2007) 174-188]', Neurobiology of Disease, 49, pp. 199, http://dx.doi.org/10.1016/j.nbd.2012.06.006

Seimon RV; Slack K; Shi Y; Zhang L; Lin S; Enriquez RF; Herzog H; Salis AS, 2013, 'Intermittent energy restriction improves fat loss efficiency in diet-induced obese mice', Obesity Research & Clinical Practice, 7, pp. e25 - e25, http://dx.doi.org/10.1016/j.orcp.2013.12.550

Menard C; Tse YC; Cavanagh C; Chabot JG; Herzog H; Schwarzer C; Wong TP; Quirion R, 2013, 'Knockdown of prodynorphin gene prevents cognitive decline, reduces anxiety, and rescues loss of group 1 metabotropic glutamate receptor function in aging', Journal of Neuroscience, 33, pp. 12792 - 12804, http://dx.doi.org/10.1523/JNEUROSCI.0290-13.2013

Zhang L; Lee I-CJ; Herzog H, 2013, 'Neuropeptide FF receptor-2 signalling is critical for diet-induced thermogenesis regulation', Obesity Research & Clinical Practice, 7, pp. e28 - e29, http://dx.doi.org/10.1016/j.orcp.2013.12.556

Wong I; Nguyen AD; Khor EC; Enriquez R; Eisman JA; Sainsbury A; Herzog H; Baldock PA, 2013, 'Neuropeptide y is a critical modulator of Leptin's regulation of cortical bone', Journal of Bone and Mineral Research, 28, pp. 886 - 898, http://dx.doi.org/10.1002/jbmr.1786

Zengin A; Nguyen AD; Wong IPL; Zhang L; Enriquez RF; Eisman JA; Herzog H; Baldock PA; Sainsbury A, 2013, 'Neuropeptide Y mediates the short-term hypometabolic effect of estrogen deficiency in mice', International Journal of Obesity, 37, pp. 390 - 398, http://dx.doi.org/10.1038/ijo.2012.71

Purtell L; Herzog H; Sainsbury A; Smith A; Loughnan G; Steinbeck KS; Campbell LV; Sze L; Viardot A, 2013, 'Postprandial cardiac autonomic function in Prader-Willi syndrome', Clinical Endocrinology, 79, pp. 128 - 133, http://dx.doi.org/10.1111/cen.12084

Herzog H, 2012, '30 Years of NPY research', Neuropeptides, 46, pp. 251, http://dx.doi.org/10.1016/j.npep.2012.10.002

Herzog H, 2012, '30Years of NPY research.', Neuropeptides, 46, pp. 251

Xi L; Jin YP; Josh P; Parker EA; Herzog H; Colgrave ML, 2012, 'A mass spectrometric assay for the quantification of neuropeptide PYY in plasma', Analytical Methods, 4, pp. 714 - 720, http://dx.doi.org/10.1039/c2ay05536h

Forbes S; Herzog H; Cox H, 2012, 'A role for neuropeptide y in the gender-specific gastrointestinal, corticosterone and feeding responses to stress', British Journal of Pharmacology, 166, pp. 2307 - 2316, http://dx.doi.org/10.1111/j.1476-5381.2012.01939.x

Zhang L; Lee I; Lau J; Lin S; Herzog H, 2012, 'Critical role of Neuropeptide FF receptor 2 in the regulation of energy balance and glucose homeostasis revealed in mice', Obesity Research & Clinical Practice, 6, pp. 17 - 17, http://dx.doi.org/10.1016/j.orcp.2012.08.035

Hurtado MD; Acosta A; Riveros PP; Baum BJ; Ukhanov K; Brown AR; Dotson CD; Herzog H; Zolotukhin S, 2012, 'Distribution of Y-Receptors in Murine Lingual Epithelia', PLoS ONE, 7, pp. e46358, http://dx.doi.org/10.1371/journal.pone.0046358

Kastenberger I; Lutsch C; Herzog H; Schwarzer C, 2012, 'Influence of sex and genetic background on anxiety-related and stress-induced behaviour of prodynorphin-deficient mice', PLoS ONE, 7, pp. Article number e34251, http://dx.doi.org/10.1371/journal.pone.0034251

Macia L; Tsai VWW; Nguyen AD; Johnen H; Kuffner T; Shi Y; Lin S; Herzog H; Brown DA; Breit SN; Sainsbury-Salis A, 2012, 'Macrophage inhibitory cytokine 1 (MIC-1/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets', PLoS One, 7, pp. e34868, http://dx.doi.org/10.1371/journal.pone.0034868

Doyle KL; Hort YJ; Herzog H; Shine J, 2012, 'Neuropeptide Y and peptide YY have distinct roles in adult mouse olfactory neurogenesis', Journal of Neuroscience Research, 90, pp. 1126 - 1135, http://dx.doi.org/10.1002/jnr.23008

Tasan RO; Verma D; Mietzsch M; Heilbronn R; Herzog H; Sperk G, 2012, 'Neuropeptide Y modulates fear and fear extinction in distinct nuclei of the amygdala', BMC Pharmacology and Toxicology, 13, http://dx.doi.org/10.1186/2050-6511-13-s1-a87

Macia L; Yulyaningsih E; Pangon L; Nguyen AD; Lin S; Shi Y; Zhang L; Bijker MS; Grey ST; Mackay F; Herzog H; Sainsbury-Salis A, 2012, 'Neuropeptide y1 receptor in immune cells regulates inflammation and insulin resistance associated with diet-induced obesity', Diabetes, 61, pp. 3228 - 3238, http://dx.doi.org/10.2337/db12-0156

Decressac M; Pain S; Chabeauti P; Frangeul L; Thiriet N; Herzog H; Vergote J; Chalon S; Jaber M; Gaillard A, 2012, 'Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease', Neurobiology of Aging, 33, pp. 2125 - 2137, http://www.ncbi.nlm.nih.gov/pubmed/21816512

Verma D; Tasan RO; Herzog H; Sperk G, 2012, 'NPY controls fear conditioning and fear extinction by combined action on Y 1 and Y 2 receptors', British Journal of Pharmacology, 166, pp. 1461 - 1473, http://dx.doi.org/10.1111/j.1476-5381.2012.01872.x

Zhang L; Nguyen A; Lee I; Yulyaningsih E; Riepler S; Stehrer B; Enriquez R; Lin S; Shi Y; Baldock PA; Sainsbury-Salis A; Herzog H, 2012, 'NPY modulates PYY function in the regulation of energy balance and glucose homeostasis', Diabetes Obesity and Metabolism, 14, pp. 727 - 736, http://dx.doi.org/10.1111/j.1463-1326.2012.01592.x

Pjetri E; Adan RAH; Herzog H; De haas R; Oppelaar H; Spierenburg HA; Olivier B; Kas M, 2012, 'NPY receptor subtype specification for behavioral adaptive strategies during limited food access', Genes Brain and Behavior, 11, pp. 105 - 112, http://dx.doi.org/10.1111/j.1601-183X.2011.00732.x

Herzog H, 2012, 'NPY: Beyond the regulation of energy metabolism', Obesity Research & Clinical Practice, 6, pp. 2 - 3, http://dx.doi.org/10.1016/j.orcp.2012.08.005

Jain P; Hassan A; Herzog H; Holzer P, 2012, 'Peptide YY and neuropeptide Y in regulation of pain and spatial learning and memory', BMC Pharmacology and Toxicology, 13, http://dx.doi.org/10.1186/2050-6511-13-s1-a58

Schmid E; Nogalo M; Bechrakis NE; Fischer-colbrie R; Tasan RO; Sperk G; Theurl M; Beer AGE; Kirchmair R; Herzog H; Troger J, 2012, 'Secretoneurin, substance P and neuropeptide Y in the oxygen-induced retinopathy in C57Bl/6N mice', Peptides, 37, pp. 252 - 257, http://dx.doi.org/10.1016/j.peptides.2012.07.024

Zhang L; Yagi M; Herzog H, 2012, 'The role of NPY and Ghrelin in anorexia nervosa', Current Pharmaceutical Design, 18, pp. 4766 - 4778, http://www.ncbi.nlm.nih.gov/pubmed/22632858

Tough IR; Forbes S; Tolhurst RS; Ellis M; Herzog H; Bornstein JC; Cox HM, 2011, 'Endogenous peptide YY and neuropeptide y inhibit colonic ion transport, contractility and transit differentially via Y1 and Y2 receptors', British Journal of Pharmacology, 164, pp. 471 - 484, http://dx.doi.org/10.1111/j.1476-5381.2011.01401.x

Nguyen AD; Lin S; Herzog H; Sainsbury A, 2011, 'Hypothalamus-specific deletion of Y1 and Y5 receptors EXACERBATES high fat diet-induced obesity', Obesity Research & Clinical Practice, 5, pp. 41 - 41, http://dx.doi.org/10.1016/j.orcp.2011.08.134

Purtell L; Sze L; Loughnan GT; Smith EM; Herzog H; Sainsbury-Salis A; Steinbeck KS; Campbell LV; Viardot A, 2011, 'In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels', Neuropeptides, 45, pp. 301 - 307, http://dx.doi.org/10.1016/j.npep.2011.06.001

Schunk E; Aigner C; Stefanova N; Wenning G; Herzog H; Schwarzer C, 2011, 'Kappa opioid receptor activation blocks progressive neurodegeneration after kainic acid injection', Hippocampus, 21, pp. 1010 - 1020, http://dx.doi.org/10.1002/hipo.20813

La Sala MS; Hurtado DM; Acosta A; Zolotukhin S; Herzog H; Dotson CD, 2011, 'Modulation of taste sensitivity and feeding by oral PYY signaling', Appetite, 57, pp. S24 - S24, http://dx.doi.org/10.1016/j.appet.2011.05.204

Nguyen AD; Herzog H; Sainsbury-Salis A, 2011, 'Neuropeptide Y and peptide YY: Important regulators of energy metabolism', Current Opinion in Endocrinology and Diabetes, 18, pp. 56 - 60, http://dx.doi.org/10.1097/MED.0b013e3283422f0a

Tasan RO; Verma D; Mietzsch M; Weger S; Heilbronn R; Herzog H; Sperk G, 2011, 'Neuropeptide Y Y2 receptors modulate trace fear conditioning and spatial memory in the dorsal hippocampus', BMC Pharmacology, 11, http://dx.doi.org/10.1186/1471-2210-11-s2-a2

Yulyaningsih E; Zhang L; Herzog H; Sainsbury-Salis A, 2011, 'NPY receptors as potential targets for anti-obesity drug development', British Journal of Pharmacology, 163, pp. 1170 - 1202, http://dx.doi.org/10.1111/j.1476-5381.2011.01363.x

Verma D; Tasan RO; Mietzsch M; Weger S; Heilbronn R; Herzog H; Sperk G, 2011, 'Reduced fear conditioning after viral vector mediated neuropeptide Y administration into the basolateral amygdala', BMC Pharmacology, 11, http://dx.doi.org/10.1186/1471-2210-11-s2-a3

Zhang X; Herzog H; Song J; Wang XL; Fan C; Guo H, 2011, 'Response properties of the electrosensory neurons in hindbrain of the white sturgeon, Acipenser transmontanus', Neurosci Bull, 27, pp. 422 - 429

Back to profile page